Nova Eye Medical Ltd (ASX: EYE) Share Price and News
Price
$0.1025
Movement
0.0025 (+2.5%)
As at 14 Mar - Closed (20 mins delayed)
52 Week Range
$0.10 - $0.30
1 Year Return
-51.19%
Nova Eye Medical Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Earnings Yield
N/A
Franking
100%
Dividend per share
N/A
Year To Date Return
-35.94%
Shares Outstanding
263.24 million
Earnings per share
-0.038
Share Price
$0.1025
Day Change
0.0025 (+2.5%)
52 Week Range
$0.10 - $0.30
Yesterday's Close
$0.10
Today's Open
$0.10
Days Range
$0.10 - $0.105
Volume
205,087
Avg. Volume (1 month)
886,867
Turnover
$20,539
As at 14 Mar - Closed
Should you invest $1,000 in Nickel Industries Limited right now?
Before you buy Nickel Industries Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 6 March 2025
Nova Eye Medical Ltd (ASX: EYE)
Latest News
Investing
3 exciting small cap healthcare shares to buy today
Investing
Why these 4 ASX shares started the week higher
Investing
Top stock picks for December
Investing
3 companies positioned to win big in 2018
Investing
5 shares you need to watch on Tuesday
Investing
2 top healthcare companies I'm watching like a hawk
Investing
Top stock picks for September
Investing
Why these 4 ASX shares are ending the week deep in the red
Investing
3 little known companies I'm watching like a hawk
Investing
3 ASX shares at 52-week lows: Are they bargain buys?
Investing
Why these 4 ASX shares are ending the week deep in the red
Investing
Why the Ellex Medical Lasers Limited share price fell 14% today
About Nova Eye Medical Ltd
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.